Elicio Therapeutics shareholders elect directors, ratify auditor, approve share issuance

Elicio Therapeutics, Inc.

Three Class I directors elected: Robert Connelly (6,248,397 for), Katie Chudnovsky (6,233,264), Allen Nissenson (6,249,739).
Ratification of Baker Tilly US, LLP as auditor for FY2024: 7,434,248 for, 1,188 against, 17,558 abstain.
Approved issuance of shares upon exercise of warrants and convertible note per Nasdaq Rule 5635(b): 6,269,593 for, 81,508 against.
Quorum of 7,452,994 shares voted (69.17% of voting power); all proposals passed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.